Acute myeloid leukemia (AML) is a type of cancer that starts in the bone marrow and rapidly progresses, affecting the production of normal blood cells. It is characterized by the rapid growth of abnormal white blood cells that crowd out the healthy cells in the bone marrow. AML is a complex and heterogeneous disease with various subtypes, and it can affect individuals of all ages. Treatment typically involves chemotherapy, radiation therapy, and stem cell transplantation. Research in AML focuses on improving treatment outcomes, understanding the genetic and molecular basis of the disease, and developing targeted therapies to improve the survival rates of patients.